Schedule 13G filing overview – The Joint Corp. (JYNT)
On 10 July 2025, Skylands Capital, LLC, a Wisconsin-based investment adviser, submitted a Schedule 13G reporting its beneficial ownership in The Joint Corp. common stock. The filing relates to an event dated 30 June 2025.
- Shares owned: 779,295
- % of outstanding class: 5.1%
- Voting power: Sole power to vote and dispose of all reported shares; no shared power
- Filing basis: Rule 13d-1(b) – passive investment by an investment adviser (IA)
- Intent statement: Securities acquired and held in the ordinary course, not for the purpose of influencing control
The disclosure means Skylands has crossed the 5 % reporting threshold, giving investors fresh insight into institutional ownership dynamics at The Joint Corp. No other entities or group relationships are identified, and there are no indications of activist intent.
Joint (NASDAQ:JYNT) agreed to sell the assets of 31 company-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $11.07 million, with closing targeted on or before 30 Jun 2025 and customary conditions attached. In return, the company will obtain regional developer rights covering 46 existing franchised clinics and 30 future development sites across Northern California, Utah, Nevada, Washington and Oregon, enlarging its franchise pipeline.
In a separate transaction, the company divested five clinics in Kansas and Missouri to 93 Chiro, LLC. Management positions both deals as part of a strategic shift toward an asset-light, royalty-driven model that increases liquidity, cuts operating costs and accelerates unit growth.